NCAB Considering Concept Review Of Large, Expensive Investigator Initiated Proposals
In Brief: Couple Gives $1.1 Mil. To NCI Intramural Research; Kuller Replaces Grufferman At PCI
Centers Urged To Apply For Comprehensive Status By June 1
Center Core Grants Could Face Cuts Of Up To 20%
Boyd Steps Down As DTP Director, Returns to Research
DeVita, Moertel Debate Timing Of Levamisole Update
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
